These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 17442710

  • 21. Retrovirus molecular conjugates: a versatile and efficient gene transfer vector system for primitive human hematopoietic progenitor cells.
    Yang G, Zhong Q, Huang W, Reiser J, Schwarzenberger P.
    Cancer Gene Ther; 2006 May; 13(5):460-8. PubMed ID: 16282988
    [Abstract] [Full Text] [Related]

  • 22. Quantitative and in vivo activity of adenoviral-producing cells made by cotransduction of a replication-defective adenovirus and a replication-enabling plasmid.
    Dion LD, Goldsmith KT, Garver RI.
    Cancer Gene Ther; 1996 May; 3(4):230-7. PubMed ID: 8853547
    [Abstract] [Full Text] [Related]

  • 23. Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.
    Paar M, Klein D, Salmons B, Günzburg WH, Renner M, Portsmouth D.
    BMC Mol Biol; 2009 Feb 09; 10():8. PubMed ID: 19203366
    [Abstract] [Full Text] [Related]

  • 24. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P, Tian J, Kovesdi I, Bruder JT.
    J Gene Med; 2008 Feb 09; 10(2):123-31. PubMed ID: 18064718
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dicistronic MLV-retroviral vectors transduce neural precursors in vivo and co-express two genes in their differentiated neuronal progeny.
    Derrington EA, López-Lastra M, Darlix JL.
    Retrovirology; 2005 Sep 29; 2():60. PubMed ID: 16194277
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc).
    Habib NA, Mitry R, Seth P, Kuppuswamy M, Doronin K, Toth K, Krajcsi P, Tollefson AE, Wold WS.
    Cancer Gene Ther; 2002 Aug 29; 9(8):651-4. PubMed ID: 12136425
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW, Mayrhofer JA, Gritschenberger W, Dorner F, Falkner FG.
    Virology; 1999 Jan 05; 253(1):107-14. PubMed ID: 9887323
    [Abstract] [Full Text] [Related]

  • 32. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
    VanBrocklin M, Federspiel MJ.
    Virology; 2000 Feb 01; 267(1):111-23. PubMed ID: 10648188
    [Abstract] [Full Text] [Related]

  • 33. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
    Higashimoto T, Urbinati F, Perumbeti A, Jiang G, Zarzuela A, Chang LJ, Kohn DB, Malik P.
    Gene Ther; 2007 Sep 01; 14(17):1298-304. PubMed ID: 17597793
    [Abstract] [Full Text] [Related]

  • 34. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
    Bastone P, Romen F, Liu W, Wirtz R, Koch U, Josephson N, Langbein S, Löchelt M.
    Gene Ther; 2007 Apr 01; 14(7):613-20. PubMed ID: 17203107
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.
    Unsinger J, Kröger A, Hauser H, Wirth D.
    Mol Ther; 2001 Nov 01; 4(5):484-9. PubMed ID: 11708885
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High efficiency retroviral vectors that contain no viral coding sequences.
    Yu SS, Kim JM, Kim S.
    Gene Ther; 2000 May 01; 7(9):797-804. PubMed ID: 10822307
    [Abstract] [Full Text] [Related]

  • 39. Factors affecting the performance of different long terminal repeats in the retroviral vector.
    Kim S, Lee K, Kim MD, Kang S, Joo CW, Kim JM, Kim SH, Yu SS, Kim S.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1017-22. PubMed ID: 16574062
    [Abstract] [Full Text] [Related]

  • 40. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
    Burton EA, Fink DJ, Glorioso JC.
    Curr Opin Mol Ther; 2005 Aug 19; 7(4):326-36. PubMed ID: 16121698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.